 |
Pegylated recombinant human megakaryocyte growth and development factor |
|---|---|
| Trade Name | Megagen |
| Orphan Indication | For reducing the period of thrombocytopenia in patients undergoing hematopoietic stem cell transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1997-10-20 00:00:00 |
| Sponsor | Amgen, Inc.;One Amgen Center Dr.;Thousand Oaks, California, 91320 |
